Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 778Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Bioindustria L.I.M. Spa
    Italy
    		 Samoh Pharmaceutical Co., Ltd. 20210218-209-J-588 Indapamide 2021-02-18 Bioindustria LIMSpA Italy Via Giustizia 1-15064 FRESONARA(AL)-ITALY (Via De Ambrosiis 2-4-6-15067 NOVI LIGURE-Italy)
    31/10/2025 Servier
    France
    		 Korea Servier Co., Ltd. 20210405-209-J-922 Indapamide 2021-04-05 ORIL Industrie France 13, rue Auguste Desgenétais, BP 17, BOLBEC, 76210, France